Cartesian Therapeutics Inc.

NASDAQ: RNAC
Share price (1/7/25): $17.16
Market cap (1/7/25): $436 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Shelf registration

Shelf registration

Shelf registration

Registration of securities for employees

Prospectus with selling stockholder info

Ownership Filter

Miljkovic Milos

Jewell Christopher M

News Filter

Announces Positive Updated Results From Phase 2b Trial of Descartes-08 in Participants With Myasthenia Gravis and Outlines Design of Planned Phase 3 Trial

Reports Third Quarter 2024 Financial Results and Provides Business Update

Shareholder Vote Results

Reports Second Quarter 2024 Financial Results and Provides Business Update

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC